Research Ethics and Compliance Officer Army Human Research Protection Office (AHRPO) Columbia, Maryland, United States
Background: The intent of the revised Common Rule is to decrease administrative burden, delay, and ambiguity for investigators, institutions, and institutional review boards (IRBs) by: o Expanding Exempt Categories, o Removing requirement for continuing review for less than greater than minimal risk (GTMR) research, and o Adding the requirement for single IRB.
Methods: Post Common Rule implementation, five (5) IRBs were evaluated by the regulatory oversight authority. IRB workload metrics for expedited and GTMR research reviews were assessed. The regulatory requirement for convened meetings, the IRB meeting minutes, IRB member training and attendance were also assessed. The overall nonexempt research portfolio for each institution was discussed with leadership to determine the likelihood for changes in volume for nonexempt research. Conclusion: Given the revisions to the Common Rule, the reallocation of burden from the IRB to the human research protection program (HRPP) is occurring. The requirement for convening an IRB meeting is clear in the Federal Regulations. There is no requirement for every organization with a Federal Assurance to maintain its own IRB. Since the implementation of the revised Common Rule, the oversight organization facilitated the disestablishment of two (2) IRBs. The primary reason was for the lack of need to review nonexempt research. The resulting findings included: IRBs convening meetings when there was no regulatory determination to be made. IRB meeting minutes reflected non-regulatorily required discussions. While IRB members understood their ethical role, there was little opportunity to apply their understanding of the criteria for IRB approval due to lack of exposure. Our experience shows that not every institution should maintain an IRB. Institutions should be considering the risk of maintaining an IRB. The risk to subjects could lie with the operation of an under-utilized IRB. IRBs that do not have ongoing exposure to reviewing GTMR studies should be critically evaluated. The time commitment for the HRPP to maintain IRB SoPs, the skill set needed to accurately create IRB meeting minutes, and the IRB members time commitment to participate in ongoing training without the exposure to active participation in convened meetings should also be assessed. Additionally, institutions could also consider the cost effectiveness or simply the added value for maintaining its own IRB.
Limitations: The limitations of this project include: IRBs assessed were limited to Department of the Army IRBs that fall under the regulatory oversight of the AHRPO; the limited number of IRBs that were evaluated (5); and the lack of regulatory guidelines for workload requirements for maintaining an effective IRB.
Discussion: The continued effectiveness of every individual IRB should be critically evaluated. The Government Accounting Office (GAO) was asked to examine independent IRBs, processes used to protect human subjects, and standards of IRB quality. The same should be done for University, Academic, and Federal Agency IRBs. IRBs that do not maintain a level of nonexempt review exposure, particularly for GTMR research, potentially impacts their effectiveness and/or expertise in the ethical and regulatory evaluation of human subjects research and should be disestablished.